Arkin Holdings is a private investment firm with a focus on healthcare and digital health investments. The company specializes in identifying and nurturing innovative companies in the life sciences and technology sectors, with a particular emphasis on digital health solutions that aim to revolutionize healthcare delivery, patient monitoring, and data management.

In 1961 Mr. Ziama Arkin founded Agis as the certified Israeli pharmaceutical importer for a number of foreign pharma companies. After the death of Mr. Ziama Arkin in 1972, his 19 year old son, Mori, took the lead, while he was serving in the IDF and completing a degree in Psychology.

In 1994, Agis purchased Clay Park and gained with it, control over its first production facility. A new era of Agis drug development and production had begun. Under Mori Arkin, who remained the principal shareholder and chairman of the board, Agis (1983) Ltd. grew to become one of the biggest leaders in the dermatological generic space in the US. In 2005 Perrigo (PRGO) purchased Agis in an $818M transaction.

COM:ARKINHOLDINGS

Arkin Holdings

Analysis Not Available